Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China 
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores 
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk 
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition 
BOJ Faces Pressure for Clarity, but Neutral Rate Estimates Likely to Stay Vague 
Tesla Expands Affordable Model 3 Lineup in Europe to Boost EV Demand 
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
European Stocks Rise as Markets Await Key U.S. Inflation Data 
Trump Administration to Secure Equity Stake in Pat Gelsinger’s XLight Startup 
U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate 
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market 
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
Microchip Technology Boosts Q3 Outlook on Strong Bookings Momentum 
Germany’s Economic Recovery Slows as Trade Tensions and Rising Costs Weigh on Growth 
Rising levels of obesity are set to cost the world economy 3.3 percent of GDP by 2060, slowing development in lower-income countries, according to a study published in BMJ Global Health.
The conditions currently cost 2.2 percent of global GDP, and the biggest increases are expected in lower-resourced countries.
In terms of absolute costs, China, the US, and India are expected to bear the brunt of the damage, with costs of $10 trillion, $2.5 trillion, and $850 billion, respectively.
The worst affected nations are anticipated to be Trinidad and Tobago with 10.2 percent of GDP and the United Arab Emirates with 11.0% of GDP being accounted for by obesity.
Both direct costs, namely medical expenses, and indirect costs from early mortality and lost output were examined in the report.
The study offers the first estimate of the economic effects of obesity, a major contributor to other non-communicable diseases like cancer, diabetes, and heart disorders, on a country-by-country basis.
According to lead author Rachel Nugent at a briefing on the margins of the UN General Assembly, nearly two in three adults globally are now living with obesity and project there would be three in four adults by 2060.
